5,921
Views
70
CrossRef citations to date
0
Altmetric
Reviews

Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations

, PhD, , PhD, & , PhD
Pages 1121-1140 | Published online: 02 Jul 2011

Bibliography

  • Granero GE, Ramachandran C, Amidon GL. Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions. Drug Dev Ind Pharm 2005;31:917-22
  • Lipinski CA, Lombardo F, Dominy BW, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3-26
  • Kanaujia P, Lau G, Ng WK, Nanoparticle formation and growth during in vitro dissolution of ketoconazole solid dispersion. J Pharm Sci 2011;100:2876-85
  • Karavas E, Ktistis G, Xenakis A, Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur J Pharm Biopharm 2006;63:103-14
  • Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930-4
  • Mihranyan A, Stromme M. Solubility of fractal nanoparticles. Surf Sci 2007;601:315-19
  • Mosharraf M, Nystrom C. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int J Pharm 1995;122:35-47
  • Hancock BC, Parks M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 2000;17:397-404
  • Dahlberg C, Millqvist-Fureby A, Schuleit M. Surface composition and contact angle relationships for differently prepared solid dispersions. Eur J Pharm Biopharm 2008;70:478-85
  • Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002;231:131-44
  • Srinarong P, Kouwen S, Visser MR, Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets. Pharm Dev Technol 2010;15:460-8
  • Patterson JE, James MB, Forster AH, Melt Extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymers. Drug Dev Ind Pharm 2008;34:95-106
  • Aso Y, Yoshioka S, Miyazaki T, Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation. Chem Pharm Bull 2007;55:1227-31
  • Cilurzo F, Minghetti P, Casiraghi A, Characterization of nifedipine solid dispersions. Int J Pharm 2002;242:313-17
  • van Drooge DJ, Hinrichs WLJ, Visser MR, Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int J Pharm 2006;310:220-9
  • Srinarong P, Faber JH, Visser MR, Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm 2009;73:154-61
  • Law D, Wang W, Schmitt EA, Prediction of Poly(Ethylene) Glycol-Drug Eutectic compositions using an index based on the van't Hoff equation. Pharm Res 2002;19:315-21
  • Newa M, Bhandari KH, Kim J-A, Preparation and evaluation of fast dissolving Ibuprofen-Polyethylene Glycol 6000 solid dispersions. Drug Deliv 2008;15:355-64
  • Okonogi S, Puttipipatkhachorn S. Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech 2006;7:E148-53
  • Zajc N, Srcic S. Binary melting phase diagrams of nifedipine-PEG 4000 and nifedipine-mannitol systems. J Therm Anal Calorim 2004;77:571-80
  • Lacoulonche F, Chauvet A, Masse J. An investigation of flurbiprofen polymorphism by thermoanalytical and spectroscopic methods and a study of its interactions with poly-(ethylene glycol) 6000 by differential scanning calorimetry and modelling. Int J Pharm 1997;153:167-79
  • Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull 1961;9:866-72
  • Baird JA, Taylor LS. Evaluation and modeling of the eutectic composition of various drug-polyethylene glycol solid dispersions. Pharm Deve Technol 2011;16:201-11
  • Vippagunta SR, Wang Z, Hornung S, Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci 2007;96:294-304
  • Liu C, Desai KGH, Liu C. Enhancement of dissolution rate of valdecoxib using solid dispersions with Polyethylene Glycol 4000. Drug Dev Ind Pharm 2005;31:1-10
  • Suzuki H, Sunada H. Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems. Chem Pharm Bull 1997;45:1688-93
  • Mura P, Manderioli A, Bramanti G, Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev Ind Pharm 1996;22:909-16
  • Law D, Wang W, Schmitt EA, Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: The eutectic microstructure. J Pharm Sci 2003;92:505-15
  • Castro SG, Bruni SS, Lanusse CE, Improved albendazole dissolution rate in Pluronic 188 solid dispersions. AAPS PharmSciTech 2010;11:1518-25
  • Karekar P, Vyas V, Shah M, Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188. Pharm Dev Technol 2009;14:373-9
  • Newa M, Bhandari KH, Li DX, Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm 2007;343:228-37
  • Sancheti PP, Karekar P, Vyas VM, Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe. Pharmazie 2009;64:227-31
  • Vyas V, Sancheti P, Karekar P, Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407. Acta Pharm 2009;59:453-61
  • Newa M, Bhandari KH, Oh DH, Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Arc Pharm Res 2008;31:1497-507
  • Andrews GP, Zhai H, Simon T, Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions. J Pharm Sci 2009;98:4545-56
  • Shah TJ, Amin AF, Parikh JR, Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. AAPS PharmSciTech 2007;8:E1-7
  • Cirri M, Maestrelli F, Corti G, Fast-dissolving tablets of glyburide based on Ternary solid dispersions with PEG 6000 and surfactants. Drug Deliv 2007;14:247-55
  • Mura P, Moyano JR, Gonzalez-Rodriguez ML, Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev Ind Pharm 2005;31:425-34
  • Ceschel G, Maffei P, Dragani M, A factor analysis for complex systems containing nimesulide. J Pharm Sci 2005;94:639-50
  • Joshi HN, Tejwani RW, Davidovich M, Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int J Pharm 2004;269:251-8
  • Mura P, Faucci MT, Manderioli A, Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev Ind Pharm 1999;25:257-64
  • Suzuki H, Sunada H. Influence of Water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem Pharm Bull 1998;46:482-7
  • Wulff M, Alden M, Craig DQM. An investigation into the critical surfactant concentration for solid solubility of hydrophobic drug in different polyethylene glycols. Int J Pharm 1996;142:189-98
  • Wulff M, Alden M. Phase equilibria in drug-polymer-surfactant systems. Thermochim Acta 1995;256:151-65
  • Sheen PC, Khetarpal VK, Cariola CM, Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int J Pharm 1995;118:221-7
  • Veiga MD, Escobar C, Bernad MJ. Dissolution behaviour of drugs from binary and ternary systems. Int J Pharm 1993;93:215-20
  • Veiga MD, Bernad MJ, Escobar C. Thermal behaviour of drugs from binary and ternary systems. Int J Pharm 1993;89:119-24
  • Sjokvist Saers E, Nystrom C, Alden M. Physicochemical aspects of drug release. XVI. The effect of storage on drug dissolution from solid dispersions and the influence of cooling rate and incorporation of surfactant. Int J Pharm 1993;90:105-18
  • Morris KR, Knipp GT, Serajuddin ATM. Structural properties of polyethylene glycol—polysorbate 80 mixture, a solid dispersion vehicle. J Pharm Sci 1992;81:1185-8
  • Craig DQM. Polyethyelene glycols and drug release. Drug Dev Ind Pharm 1990;16:2501-26
  • Alden M, Tegenfeldt J, Sjokvist E. Structure of solid dispersions in the system polyethylene glycol-griseofulvin with additions of sodium dodecyl sulphate. Int J Pharm 1982;83:47-52
  • Bley H, Fussnegger B, Bodmeier R. Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm 2010;390:165-73
  • Crowley MM, Zhang F, Repka MA, Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 2007;33:909-26
  • Chokshi R, Zia H. Hot-melt extrusion technique: a review. Iran J Pharm Res 2004;3:3-16
  • Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107-17
  • Meltrex technology for melt-extrusion for solid dosage forms. Available from: http://www.soliqs.com/Meltrex-R.15.0.html [Last accessed 16 May 2011]
  • Improve solubility - The process. Available form http://www.meltdose.com/process.cfm [Last accessed 16 May 2011]
  • Forster A, Hempenstall J, Tucker I, The potential of small-scale fusion experiments and the gordon-taylor equation to predict the suitability of drug/polymer blends for melt extrusion. Drug Dev Ind Pharm 2001;27:549-60
  • Marsac PJ, Li T, Taylor LS. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res 2009;26:139-51
  • Forster A, Hempenstall J, Tucker I, Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 2001;226:147-61
  • Greenhalgh DJ, Williams AC, Timmins P, Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci 1999;88:1182-90
  • Forster A, Hempenstall J, Rades T. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J Pharm Pharmacol 2001;53:303-15
  • He H, Yang R, Tang X. In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm 2010;36:681-7
  • Jijun F, Lili Z, Tingting G, Stable nimodipine tablets with high bioavailability containing NM-SD prepared by hot-melt extrusion. Powder Technol 2010;204:214-21
  • Fukuda M, Miller DA, Peppas NA, Influence of sulfobutyl ether beta-cyclodextrin (Captisol®) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion. Int J Pharm 2008;350:188-96
  • Verreck G, Six K, Van den Mooter G, Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion - Part I. Int J Pharm 2003;251:165-74
  • Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Int J Pharm 2007;328:119-29
  • Ghebremeskel A, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions. Pharm Res 2006;23:1928-36
  • Schilling SU, Shah NH, Malick AW, Citric acid as a solid-state plasticizer for Eudragit RS PO. J Pharm Pharmacol 2007;59:1493-500
  • Wu C, McGinity JW. Influence of methylparaben as a solid-state plasticizer on the physicochemical properties of Eudragit® RS PO hot-melt extrudates. Eur J Pharm Biopharm 2003;56:95-100
  • Verreck G, Decorte A, Li H, The effect of pressurized carbon dioxide as a plasticizer and foaming agent on the hot melt extrusion process and extrudate properties of pharmaceutical polymers. J Supercrit Fluid 2006;38:383-91
  • Andrews GP, AbuDiak OA, Jones DS. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. J Pharm Sci 2010;99:1322-35
  • DiNunzio JC, Brough C, Hughey JR, Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing. Eur J Pharm Biopharm 2010;74:340-51
  • Andrews GP, Abu-Diak O, Kusmanto F, Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharmacol 2010;62:1580-90
  • Patyi G, Bodis A, Antal I, Thermal and spectroscopic analysis of inclusion complex of spironolactone prepared by evaporation and hot melt methods. J Therm Anal Calorim 2010;102:349-55
  • Tho I, Liepold B, Rosenberg J, Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media. Eur J Pharm Sci 2010;40:25-32
  • Albers J, Alles R, Matthe K, Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. Eur J Pharm Biopharm 2009;71:387-94
  • Lakshman JP, Cao Y, Kowalski J, Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharm 2008;5:994-1002
  • Chokshi RJ, Shah NH, Sandhu HK, Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. J Pharm Sci 2008;97:2286-98
  • Miller D, DiNunzio J, Yang W, Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption. Pharm Res 2008;25:1450-9
  • Chokshi RJ, Sandhu HK, Iyer RM, Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution. J Pharm Sci 2005;94:2463-74
  • Rambali B, Verreck G, Baert L, Itraconazole formulation studies of the melt-extrusion process with mixture design. Drug Dev Ind Pharm 2003;29:641-52
  • Hulsmann S, Backensfeld T, Keitel S, Melt extrusion - an alternative method for enhancing the dissolution rate of 17[beta]-estradiol hemihydrate. Eur J Pharm Biopharm 2000;49:237-42
  • Nekkanti V, Muniyappan T, Karatgi P, Spray-drying process optimization for manufacture of drug-cyclodextrin complex powder using design of experiments. Drug Dev Ind Pharm 2009;35:1219-29
  • Cabral-Marques H, Almeida R. Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/cyclodextrin inclusion complexes. Eur J Pharm Biopharm 2009;73:121-9
  • Esposito E, Roncarati R, Cortesi R, Production of eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics. Pharm Dev Technol 2000;5:267-78
  • Dobry D, Settell D, Baumann J, A model-based methodology for spray-drying process development. J Pharm Innov 2009;4:133-42
  • Rizi K, Green RJ, Donaldson M, Production of pH-responsive microparticles by spray drying: investigation of experimental parameter effects on morphological and release properties. J Pharm Sci 2011;100:566-79
  • Joe JH, Lee WM, Park Y-J, Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm 2010;395:161-6
  • Nekkanti V, Pillai R, Venkateshwarlu V, Development and characterization of solid oral dosage form incorporating candesartan nanoparticles. Pharm Dev Technol 2009;14:290-8
  • Chaubal M, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res 2008;25:2302-8
  • Vogt M, Kunath K, Dressman JB. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm 2008;68:283-8
  • Dolenc A, Kristl J, Baumgartner S, Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm 2009;376:204-12
  • Gao Y, Qian S, Zhang J. Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension. Chem Pharm Bull 2010;58:912-17
  • Wikarsa S, Durand D, Delarbre J-L, The improvement of ibuprofen dissolution rate through microparticles spray drying processed in an aqueous system. Drug Dev Ind Pharm 2008;34:485-91
  • Ambike AA, Mahadik KR, Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm Res 2005;22:990-8
  • Chauhan B, Shimpi S, Paradkar A. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur J Pharm Sci 2005;26:219-30
  • Muller CR, Bassani VL, Pohlmann AR, Preparation and characterization of spray-dried polymeric nanocapsules. Drug Dev Ind Pharm 2000;26:343-7
  • Wu K, Li J, Wang W, Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent. J Pharm Sci 2009;98:2422-31
  • Weuts I, Kempen D, Verreck G, Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying. Eur J Pharm Biopharm 2005;59:119-26
  • Abdelwahed W, Degobert G, Stainmesse S, Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Deliv Rev 2006;58:1688-713
  • Ni N, Tesconi M, Tabibi SE, Use of pure t-butanol as a solvent for freeze-drying: a case study. Int J Pharm 2001;226:39-46
  • Kasraian K, DeLuca PP. Thermal analysis of the tertiary butyl alcohol-water system and its implications on freeze-drying. Pharm Res 1995;12:484-90
  • van Drooge DJ, Hinrichs WLJ, Frijlink HW. Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent. J Pharm Sci 2004;93:713-25
  • Campbell AN, Bailey RA. The system lithium nitrate-ethanol-water and its component binary systems. Can J Chem 1958;36:518-36
  • Kasraian K, DeLuca PP. The Effect of tertiary butyl alcohol on the resistance of the dry product layer during primary drying. Pharm Res 1995;12:491-5
  • Takada A, Nail S, Yonese M. Influence of ethanol on physical state of freeze-dried mannitol. Pharm Res 2009;26:1112-20
  • Onoue S, Takahashi H, Kawabata Y, Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci 2010;99:1871-81
  • Teagarden DL, Baker DS. Practical aspects of lyophilization using non-aqueous co-solvent systems. Eur J Pharm Sci 2002;15:115-33
  • Rogers TL, Nelsen AC, Hu J, A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur J Pharm Biopharm 2002;54:271-80
  • Hu J, Rogers T, Brown J, Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology. Pharm Res 2002;19:1278-84
  • Purvis T, Mattucci M, Crisp M, Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process. AAPS PharmSciTech 2007;8:E52-60
  • de Waard H, Grasmeijer N, Hinrichs WLJ, Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production. Eur J Pharm Sci 2009;38:224-9
  • Van Eerdenbrugh B, Froyen L, Van Humbeeck J, Drying of crystalline drug nanosuspensions–The importance of surface hydrophobicity on dissolution behavior upon redispersion. Eur J Pharm Sci 2008;35:127-35
  • Van Eerdenbrugh B, Froyen L, Martens JA, Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int J Pharm 2007;338:198-206
  • Mauludin R, Muller RH, Keck CM. Kinetic solubility and dissolution velocity of rutin nanocrystals. Eur J Pharm Sci 2009;36:502-10
  • Van Eerdenbrugh B, Froyen L, Van Humbeeck J, Alternative matrix formers for nanosuspension solidification: dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion. Eur J Pharm Sci 2008;35:344-53
  • Srinarong P, Hamalainen S, Visser MR, Surface-active derivative of inulin (Inutec® SP1) is a superior carrier for solid dispersions with a high drug load. J Pharm Sci 2011;100:2333-42
  • Elgindy N, Elkhodairy K, Molokhia A, Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide. Eur J Pharm Biopharm 2010;74:397-405
  • Kondo M, Niwa T, Okamoto H, Particle Characterization of poorly water-soluble drugs using a spray freeze drying technique. Chem Pharm Bull 2009;57:657-62
  • van Drooge DJ, Hinrichs WLJ, Frijlink HW. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J Control Release 2004;97:441-52
  • Yasuji T, Takeuchi H, Kawashima Y. Particle design of poorly water-soluble drug substances using supercritical fluid technologies. Adv Drug Deliv Rev 2008;60:388-98
  • Subramaniam B, Rajewski RA, Snavely K. Pharmaceutical processing with supercritical carbon dioxide. J Pharm Sci 1997;86:885-90
  • Krukonis VJ. Supercritical fluid nucleation of difficult to comminute solids. Proc Annual Meeting AIChE 1984, Paper 104f:T-214
  • Charoenchaitrakool M, Dehghani F, Foster NR, Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind Eng Chem Res 2000;39:4794-802
  • Alessi P, Cortesi A, Kikic I, Particle production of steroid drugs using supercritical fluid processing. Ind Eng Chem Res 1996;35:4718-26
  • Van Hees T, Piel G, Evrard B, Application of supercritical carbon dioxide for the preparation of a Piroxicam-beta-Cyclodextrin inclusion compound. Pharm Res 1999;16:1864-70
  • Gallagher PM, Coffey MP, Krukonis VJ, Gas Antisolvent Recrystallization: new process to recrystallize compounds insoluble in supercritical fluids. Supercrit Fluid Sci Technol 1989;406:334-54
  • Pasquali I, Bettini R, Giordano F. Supercritical fluid technologies: An innovative approach for manipulating the solid-state of pharmaceuticals. Adv Drug Deliv Rev 2008;60:399-410
  • Kluge J, Fusaro F, Muhrer G, Rational design of drug-polymer co-formulations by CO2 anti-solvent precipitation. J Supercrit Fluid 2009;48:176-82
  • Majerik V, Charbit G, Badens E, Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. J Supercrit Fluid 2007;40:101-10
  • Lim RTY, Ng WK, Tan RBH. Amorphization of pharmaceutical compound by co-precipitation using supercritical anti-solvent (SAS) process (Part I). J Supercrit Fluid 2010;53:179-84
  • Kim M-S, Kim J-S, Hwang S-J. Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives. Chem Pharm Bull 2010;58:230-3
  • Lee S-Y, Jung I-I, Kim J-K, Preparation of itraconazole/HP-[beta]-CD inclusion complexes using supercritical aerosol solvent extraction system and their dissolution characteristics. J Supercrit Fluid 2008;44:400-8
  • Won D-H, Kim M-S, Lee S, Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int J Pharm 2005;301:199-208
  • Jun SW, Kim M-S, Jo GH, Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids. J Pharm Pharmacol 2005;57:1529-37
  • Lee S, Nam K, Kim M, Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability. Arch Pharm Res 2005;28:866-74
  • Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272:1-10
  • Juppo AM, Boissier C, Khoo C. Evaluation of solid dispersion particles prepared with SEDS. Int J Pharm 2003;250:385-401
  • Sethia S, Squillante E. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J Pharm Sci 2002;91:1948-57
  • Moneghini M, Kikic I, Voinovich D, Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution. Int J Pharm 2001;222:129-38
  • Sencar-Bozic P, Srcic S, Knez Z, Improvement of nifedipine dissolution characteristics using supercritical CO2. Int J Pharm 1997;148:123-30
  • Janssens S, Van den Mooter G. Review: physical chemistry of solid dispersions. J Pharm Pharmacol 2009;61:1571-86

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.